Platelets in chronic liver disease, from bench to bedside

被引:52
|
作者
Ramadori, Pierluigi [1 ]
Klag, Thomas [2 ]
Malek, Nisar Peter [2 ]
Heikenwalder, Mathias [1 ]
机构
[1] German Canc Res Ctr Heidelberg DKFZ, Div Chron Inflammat & Canc, Neuenheimer Feld 280, D-69120 Heidelberg, Germany
[2] Univ Tubingen, Dept Internal Med 1, Muller Str 10, D-72076 Tubingen, Germany
关键词
Platelets; cirrhosis; HCC; cancer; immune system; immunology; NASH; NAFLD; LOW-DOSE ASPIRIN; HEPATOCELLULAR-CARCINOMA; GROWTH-FACTOR; PARTIAL-HEPATECTOMY; IMPROVES SURVIVAL; HCV INFECTION; KUPFFER CELLS; DRUG-THERAPY; MOUSE MODEL; LIFE-SPAN;
D O I
10.1016/j.jhepr.2019.10.001
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
In the last decade, numerous studies revealed physiologic and pathophysiologic roles of platelets beyond haemostasis, a process to prevent and stop bleeding. These include the activation of the immune system and the promotion of inflammation, infection and cancer. Hence, the emerging view on the role of platelets has shifted - platelets are nowseen as alert "sentinels" of the immune compartment, rather than passive bystanders. Herein, we review well-established and newly discovered features of platelets that define their natural role in maintaining blood haemostasis, but also their functional relationship with other cells of the immune system. We focus on recent studies underlining functional involvement of platelets in chronic liver diseases and cancer, as well as the effects of anti-platelet therapy in these contexts. Finally, we illustrate the potential of platelets as possible diagnostic and therapeutic tools in liver disease based on recently developed methodologies. (c) 2019 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:448 / 459
页数:12
相关论文
共 50 条
  • [1] Endogenous opioid peptides and chronic liver disease: From bedside to bench
    Marzioni, Marco
    Baroni, Gianluca Svegliati
    Alpini, Gianfranco
    Benedetti, Antonio
    JOURNAL OF HEPATOLOGY, 2007, 46 (04) : 583 - 586
  • [2] Alcoholic Liver Disease: From Bench to Bedside
    Abenavoli, Ludovico
    REVIEWS ON RECENT CLINICAL TRIALS, 2016, 11 (03) : 158 - 158
  • [3] Alcoholic Liver Disease: From Bench to Bedside
    Abenavoli, Ludovico
    REVIEWS ON RECENT CLINICAL TRIALS, 2019, 14 (03) : 158 - 159
  • [4] Resveratrol and liver disease: from bench to bedside and community
    Bishayee, Anupam
    Darvesh, Altaf S.
    Politis, Themos
    McGory, Robb
    LIVER INTERNATIONAL, 2010, 30 (08) : 1103 - 1114
  • [5] Sarcopenia in chronic kidney disease: from bench to bedside
    Kim, Da Woon
    Song, Sang Heon
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2023, 38 (03): : 303 - 321
  • [6] Lipoproteins in chronic kidney disease: from bench to bedside
    Speer, Thimoteus
    Ridker, Paul M.
    von Eckardstein, Arnold
    Schunk, Stefan J.
    Fliser, Danilo
    EUROPEAN HEART JOURNAL, 2021, 42 (22) : 2170 - 2185
  • [7] CHRONIC INFLAMMATORY BOWEL DISEASE - FROM BENCH TO BEDSIDE
    Neurath, M. F.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S10 - S10
  • [8] MicroRNAs in Liver Disease: Bench to Bedside
    Shah, Nihar
    Nelson, James E.
    Kowdley, Kris V.
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2013, 3 (03) : 231 - 242
  • [9] FROM BENCH TO BEDSIDE: IS THE ROAD TRICKIER IN ALCOHOLIC LIVER DISEASE?
    Hadengue, A.
    Spahr, L.
    ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2010, 34 (08) : 53A - 53A
  • [10] Liver Diseases: From Bench to Bedside
    Kanda, Tatsuo
    Sasaki-Tanaka, Reina
    Terai, Shuji
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (10)